Omalizumab in severe allergic asthma

10th May 2013 by Louise Hudman

This guideline advises that Omalizumab can be used in the treatment of asthma. It is a monoclonal antibody that binds to IgE and is given every 2 to 4 weeks subcut. We may start seeing patients treated with this, so worth knowing about it. Treatment is to be started and maintained by specialists only. Quite a lot of criteria must be met before use, so it’ll only be used in the most severe asthma, where allergy testing has been positive.

Join

Join to view the rest of this content, as well as access all the benefits of joining NASGP.

Join

Login

Already a member? Login to view this content.

Login

"I am a newly qualified sessional GP. I am thankful to you and your team for the splendid work you do for all of us. LocumDeck is the only platform that allows GPs to be in control and I am glad I have been a member of NASGP since my trainee days."

Dr Karthik Krishna

See the full list of features within our NASGP membership plans

Membership